{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:25:40Z","timestamp":1791278740206,"version":"4.1.0"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1097\/01.aids.0000192081.33938.2f","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T04:01:56Z","timestamp":1130299316000},"page":"S128-S134","source":"Crossref","is-referenced-by-count":56,"title":["Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications"],"prefix":"10.1097","volume":"19","author":[{"given":"Patrice","family":"Cacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Limal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marc","family":"L\u00e9ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-20-20210130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C","volume":"132","author":"Liang","year":"2000","journal-title":"Ann Intern Med"},{"key":"R3-20-20210130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R4-20-20210130","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R5-20-20210130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients","volume":"69","author":"Gorevic","year":"1980","journal-title":"Am J Med"},{"key":"R6-20-20210130","first-page":"889","article-title":"Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations","volume":"19","author":"Ferri","year":"1992","journal-title":"J Rheumatol"},{"key":"R7-20-20210130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1212\/01.WNL.0000044399.71601.EA","article-title":"Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy","volume":"60","author":"Authier","year":"2003","journal-title":"Neurology"},{"key":"R8-20-20210130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1212\/WNL.53.4.861","article-title":"Neurologic complications associated with hepatitis C virus infection","volume":"53","author":"Tembl","year":"1999","journal-title":"Neurology"},{"key":"R9-20-20210130","first-page":"115","article-title":"Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias","volume":"88","author":"Monti","year":"1995","journal-title":"Q J Med"},{"key":"R10-20-20210130","first-page":"920","article-title":"Neurological manifestations in cryoglobulinemia [in French]","volume":"158","author":"Maisonobe","year":"2002","journal-title":"Rev Neurol (Paris)"},{"key":"R11-20-20210130","first-page":"109","article-title":"Systemic vasculitis in patients with hepatitis C","volume":"28","author":"Cacoub","year":"2001","journal-title":"J Rheumatol"},{"key":"R12-20-20210130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0676.1998.tb00126.x","article-title":"Hepatitis C associated with Guillain\u2013Barre syndrome","volume":"18","author":"Lacaille","year":"1998","journal-title":"Liver"},{"key":"R13-20-20210130","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","article-title":"Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia","volume":"74","author":"Nemni","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R14-20-20210130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0248-8663(01)00452-0","article-title":"Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia [in French]","volume":"22","author":"Lidove","year":"2001","journal-title":"Rev Med Interne"},{"key":"R15-20-20210130","first-page":"403","article-title":"Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment [in French]","volume":"23","author":"Lidove","year":"1999","journal-title":"Gastroenterol Clin Biol"},{"key":"R16-20-20210130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.10118","article-title":"Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review","volume":"25","author":"Boonyapisit","year":"2002","journal-title":"Muscle Nerve"},{"key":"R17-20-20210130","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/art.1780401113","article-title":"Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia","volume":"40","author":"Agnello","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R18-20-20210130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s004280050380","article-title":"Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia","volume":"434","author":"Bonetti","year":"1999","journal-title":"Virchows Arch"},{"key":"R19-20-20210130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(95)92211-3","article-title":"Hepatitis C infection and polymyositis","volume":"346","author":"Ueno","year":"1995","journal-title":"Lancet"},{"key":"R20-20-20210130","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"key":"R21-20-20210130","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"key":"R22-20-20210130","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","article-title":"Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection","volume":"90","author":"Casato","year":"1997","journal-title":"Blood"},{"key":"R23-20-20210130","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"R24-20-20210130","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"R25-20-20210130","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"R26-20-20210130","first-page":"2466","article-title":"Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection","volume":"28","author":"Naarendorp","year":"2001","journal-title":"J Rheumatol"},{"key":"R27-20-20210130","first-page":"2172","article-title":"Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha","volume":"27","author":"Zuckerman","year":"2000","journal-title":"J Rheumatol"},{"key":"R28-20-20210130","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/art.10699","article-title":"Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"46","author":"Cacoub","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R29-20-20210130","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","article-title":"Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study","volume":"84","author":"Dammacco","year":"1994","journal-title":"Blood"},{"key":"R30-20-20210130","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"R31-20-20210130","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1080\/1042819031000119235","article-title":"Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases","volume":"44","author":"Zaja","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"R32-20-20210130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.510300312","article-title":"Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence","volume":"30","author":"Cerny","year":"1999","journal-title":"Hepatology"},{"key":"R33-20-20210130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.510270132","article-title":"Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis","volume":"27","author":"Foster","year":"1998","journal-title":"Hepatology"},{"key":"R34-20-20210130","first-page":"1355","article-title":"Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients","volume":"94","author":"Barkhuizen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R35-20-20210130","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0168-8278(02)00067-3","article-title":"Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C","volume":"36","author":"Cacoub","year":"2002","journal-title":"J Hepatol"},{"key":"R36-20-20210130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jhep.2002.30688","article-title":"Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease","volume":"35","author":"Forton","year":"2002","journal-title":"Hepatology"},{"key":"R37-20-20210130","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1572-0241.1998.225_a.x","article-title":"Hepatitis C virus and depression in drug users","volume":"93","author":"Johnson","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R38-20-20210130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/jhep.2002.31257","article-title":"Neuropsychological impairment in patients with chronic hepatitis C","volume":"35","author":"Hilsabeck","year":"2002","journal-title":"Hepatology"},{"key":"R39-20-20210130","first-page":"484","article-title":"Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case\u2013control study using magnetic resonance imaging and neuropsychological tests","volume":"32","author":"Casato","year":"2005","journal-title":"J Rheumatol"},{"key":"R40-20-20210130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/JVI.76.2.600-608.2002","article-title":"Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication","volume":"76","author":"Radkowski","year":"2002","journal-title":"J Virol"},{"issue":"Suppl. 1","key":"R41-20-20210130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-8278(04)90394-7","article-title":"Tryptophan\/Kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology [Abstract]","volume":"40","author":"Zignego","year":"2004","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"R42-20-20210130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(04)90512-0","article-title":"Serotonergic dysfunction during chronic hepatitis C infection among patients with drug addiction compared to controls [Abstract]","volume":"40","author":"Schaefer","year":"2004","journal-title":"J Hepatol"},{"key":"R43-20-20210130","first-page":"1061","article-title":"Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences [in French]","volume":"25","author":"Roudot-Thoraval","year":"2001","journal-title":"Gastroenterol Clin Biol"},{"key":"R44-20-20210130","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-127-10-199711150-00003","article-title":"Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy","volume":"127","author":"Marcellin","year":"1997","journal-title":"Ann Intern Med"},{"key":"R45-20-20210130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bmj.2.4882.279","article-title":"Cryoglobulinaemia with cerebral purpura","volume":"4882","author":"Marshall","year":"1954","journal-title":"BMJ"},{"key":"R46-20-20210130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/archneur.1976.00500010007002","article-title":"Hypoxic\u2013ischemic leukoencephalopathy in man","volume":"33","author":"Ginsberg","year":"1976","journal-title":"Arch Neurol"},{"key":"R47-20-20210130","first-page":"208","article-title":"Central nervous system involvement in patients with HCV-related cryoglobulinemia","volume":"315","author":"Origgi","year":"1998","journal-title":"Am J Med Sci"},{"key":"R48-20-20210130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0025-6196(11)63005-X","article-title":"Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia","volume":"71","author":"Petty","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"R49-20-20210130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s004150050388","article-title":"Neurological manifestations of chronic hepatitis C","volume":"246","author":"Heckmann","year":"1999","journal-title":"J Neurol"},{"key":"R50-20-20210130","first-page":"631","article-title":"Central nervous system involvement in hepatitis C virus infection [in French]","volume":"22","author":"Cacoub","year":"1998","journal-title":"Gastroenterol Clin Biol"},{"key":"R51-20-20210130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004836-199701000-00009","article-title":"HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident. Response to interferon therapy","volume":"24","author":"Malnick","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"R52-20-20210130","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0002-9270(01)02622-3","article-title":"Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and serious manifestations","volume":"96","author":"Mendez","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R53-20-20210130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.24.3.245","article-title":"Neurologic manifestations in patients with mixed cryoglobulinemia","volume":"24","author":"Abramsky","year":"1974","journal-title":"Neurology"},{"key":"R54-20-20210130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/pgmj.58.680.359","article-title":"Cerebral involvement in primary mixed cryoglobulinaemia","volume":"58","author":"Pines","year":"1982","journal-title":"Postgrad Med J"},{"key":"R55-20-20210130","first-page":"2273","article-title":"Isolated central nervous system vasculitis associated with hepatitis C infection","volume":"26","author":"Dawson","year":"1999","journal-title":"J Rheumatol"},{"key":"R56-20-20210130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jmv.1890330307","article-title":"Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus","volume":"33","author":"Hayashi","year":"1991","journal-title":"J Med Virol"},{"key":"R57-20-20210130","first-page":"602","article-title":"Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study","volume":"6","author":"Eyster","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R58-20-20210130","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/clinids\/23.5.1117","article-title":"Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections","volume":"23","author":"Zylberberg","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R59-20-20210130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/clinids\/18.3.339","article-title":"Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses","volume":"18","author":"Horvath","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R60-20-20210130","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/01.WNL.0000115177.74976.6C","article-title":"Neuropsychiatric impact of hepatitis C on advanced HIV","volume":"62","author":"Ryan","year":"2004","journal-title":"Neurology"},{"key":"R61-20-20210130","first-page":"2005","article-title":"Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients","volume":"30","author":"Bonnet","year":"2003","journal-title":"J Rheumatol"},{"key":"R62-20-20210130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10096-002-0823-0","article-title":"Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy","volume":"21","author":"Macias","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R63-20-20210130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/345953","article-title":"Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy","volume":"36","author":"Tedaldi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R64-20-20210130","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00002030-200308150-00009","article-title":"Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 Study)","volume":"17","author":"Rosenthal","year":"2003","journal-title":"AIDS"},{"key":"R65-20-20210130","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study","volume":"356","author":"Greub","year":"2000","journal-title":"Lancet"},{"key":"R66-20-20210130","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1086\/425360","article-title":"Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study","volume":"39","author":"Anderson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R67-20-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.20541","article-title":"The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection","volume":"41","author":"Mehta","year":"2005","journal-title":"Hepatology"},{"key":"R68-20-20210130","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.292.23.2839","article-title":"Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial","volume":"292","author":"Carrat","year":"2004","journal-title":"JAMA"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.aids.0000192081.33938.2f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:03:50Z","timestamp":1785855830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200510003-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":68,"journal-issue":{"issue":"Suppl 3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000192081.33938.2f","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}